e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Variability of primary resistant M.tuberculosis strains in TB service institutions
A. Rogozhin (Kharkiv, Ukraine), P. Poteiko (Kharkiv, Ukraine), O. Konstantynoska (Kharkiv, Ukraine), O. Liashenko (Kharkiv, Ukraine), O. Solodiankin (Kharkiv, Ukraine)
Source:
International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Session:
Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Session type:
Thematic Poster
Number:
4753
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Rogozhin (Kharkiv, Ukraine), P. Poteiko (Kharkiv, Ukraine), O. Konstantynoska (Kharkiv, Ukraine), O. Liashenko (Kharkiv, Ukraine), O. Solodiankin (Kharkiv, Ukraine). Variability of primary resistant M.tuberculosis strains in TB service institutions. 4753
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Clinical and genotypic pattern of multidrug resistant tuberculosis isolated from extrapulmonary tuberculosis cases in tertiary care hospitals in northern India
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Primary drug resistant
Mycobacterium tuberculosis
in a tertiary TB center in Iran
Source: Eur Respir J 2005; 26: Suppl. 49, 651s
Year: 2005
Primary drug resistance against mycobacterium tuberculosis in a high burden country
Source: Eur Respir J 2006; 28: Suppl. 50, 587s
Year: 2006
Multidrug resistance of
M. tuberculosis
and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus
Source: Eur Respir J 2007; 30: Suppl. 51, 272s
Year: 2007
Resistance to pyrazinamide of
Mtb
strains in TB institute clinic
Source: Eur Respir J 2007; 30: Suppl. 51, 413s
Year: 2007
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Drug resistant tuberculosis at a drug resistant tuberculosis centre, India- Analysis of outcome
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India?
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Study of drug resistance profile in Multidrug resistant tuberculosis (MDR TB) patients attending a tertiary care hospital at Mumbai.
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Molecular surveillance of multi-drug resistant tuberculosis in Europe
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Laboratory system to detect multidrug-resistant (MDR) and extensively drug-resistant (XDR)
mycobacterium tuberculosis
strains in clinical practice
Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Year: 2008
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept